Bioextrax AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
For the six months, sales was SEK 0.242474 million compared to SEK 0.04 million a year ago. Revenue was SEK 0.917016 million compared to SEK 0.066284 million a year ago. Net loss was SEK 8.27 million compared to SEK 5.07 million a year ago. Basic loss per share from continuing operations was SEK 0.5449 compared to SEK 0.3437 a year ago.